Patent ID: 7172888

Claim:
A biological composition comprising activated yeast cells, wherein said activated yeast cells are cells of Saccharomyces cerevisiae Hansen strain IFFI1345 and are characterized by their ability to retard the growth of lung cancer cells in mammals as compared to yeast cells of said strain not having been so activated, wherein said activated yeast cells are prepared by using yeast cells of Saccharomyces cerevisiae Hansen strain IFFI1345 in a method comprising at least two steps selected from the group consisting of: (a) culturing said yeast cells in a first electromagnetic field having a frequency in the range of 8,046 to 8,056 MHz and a field strength in the range of 240 to 300 mV/cm; (b) culturing said yeast cells in a second electromagnetic field having a frequency in the range of 8,077 to 8,087 MHz and a field strength in the range of 226 to 285 mV/cm; (c) culturing said yeast cells in a third electromagnetic field having a frequency in the range of 9,907 to 9,917 MHz and a field strength in the range of 325 to 366 mV/cm; (d) culturing said yeast cells in a fourth electromagnetic field having a frequency in the range of 12,716 to 12,726 MHz and a field strength in the range of 386 to 412 mV/cm; and (e) culturing said yeast cells in a fifth electromagnetic field having a frequency in the range of 12,750 to 12,760 MHz and a field strength in the range of 295 to 315 mV/cm.